HK1258584A1 - 用於製備減毒四價登革熱疫苗的方法 - Google Patents
用於製備減毒四價登革熱疫苗的方法Info
- Publication number
- HK1258584A1 HK1258584A1 HK19100940.0A HK19100940A HK1258584A1 HK 1258584 A1 HK1258584 A1 HK 1258584A1 HK 19100940 A HK19100940 A HK 19100940A HK 1258584 A1 HK1258584 A1 HK 1258584A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparing
- dengue vaccine
- tetravalent dengue
- attenuated tetravalent
- attenuated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
- B65B3/003—Filling medical containers such as ampoules, vials, syringes or the like
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24161—Methods of inactivation or attenuation
- C12N2770/24164—Methods of inactivation or attenuation by serial passage
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Mechanical Engineering (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/847,422 US10004795B2 (en) | 2015-09-08 | 2015-09-08 | Process for preparing an attenuated tetravalent dengue vaccine |
PCT/BR2016/050224 WO2017041156A1 (en) | 2015-09-08 | 2016-09-06 | Process for preparing an attenuated tetravalent dengue vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1258584A1 true HK1258584A1 (zh) | 2019-11-15 |
Family
ID=56268413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK19100940.0A HK1258584A1 (zh) | 2015-09-08 | 2019-01-22 | 用於製備減毒四價登革熱疫苗的方法 |
Country Status (17)
Country | Link |
---|---|
US (2) | US10004795B2 (zh) |
EP (1) | EP3347043A1 (zh) |
JP (1) | JP6968070B2 (zh) |
CN (1) | CN108289945B (zh) |
AR (1) | AR105966A1 (zh) |
AU (1) | AU2016318349B2 (zh) |
BR (1) | BR102015030332B1 (zh) |
CL (1) | CL2018000609A1 (zh) |
CO (1) | CO2018003451A2 (zh) |
CR (1) | CR20180202A (zh) |
CU (1) | CU24579B1 (zh) |
EC (1) | ECSP18026090A (zh) |
HK (1) | HK1258584A1 (zh) |
MX (2) | MX2018002901A (zh) |
PE (1) | PE20181135A1 (zh) |
TW (1) | TWI733694B (zh) |
WO (1) | WO2017041156A1 (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3177574A1 (en) | 2013-03-15 | 2014-09-25 | Takeda Vaccines, Inc. | Compositions and methods for dengue virus chimeric constructs in vaccines |
US10004795B2 (en) | 2015-09-08 | 2018-06-26 | Fundacao Butantan | Process for preparing an attenuated tetravalent dengue vaccine |
PE20210106A1 (es) | 2017-10-16 | 2021-01-19 | Serum Institute Of India Pvt Ltd | Composiciones de vacuna estables que comprenden inter alia un flavivirus recombinante vivo atenuado y proceso para la preparacion de las mismas |
WO2019112921A1 (en) | 2017-12-07 | 2019-06-13 | Merck Sharp & Dohme Corp. | Formulations of dengue virus vaccine compositions |
US20220226401A1 (en) | 2018-09-05 | 2022-07-21 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
US11464815B2 (en) | 2018-09-05 | 2022-10-11 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
WO2023044774A1 (en) * | 2021-09-24 | 2023-03-30 | Sichuan Clover Biopharmaceuticals, Inc. | Tpo mimetic fusion proteins and methods of use submission of sequence listing as ascii text file |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2338508B1 (en) * | 2002-05-03 | 2018-02-14 | The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services | A rDEN3/4delta 30(ME), rDEN2/4delta30(ME) or rDEN1/4delta30(ME) recombinant chimeric dengue virus containing a 30 nucleotide deletion (delta30) in a section of the 3' untranslated region of dengue type 4 genome, wherein said 30 nucleotide deletion corresponds to the TL2 stem-loop structure |
GB0304799D0 (en) * | 2003-03-03 | 2003-04-09 | Glaxosmithkline Biolog Sa | Novel method |
ATE502104T1 (de) * | 2003-12-19 | 2011-04-15 | Wyeth Llc | Serumfreies vero-zellbanken-herstellungsverfahren |
WO2006066332A1 (en) * | 2004-12-23 | 2006-06-29 | Murray Goulburn Co-Operative Co Limited | Method of manufacture of a modified milk powder suitable as a rennet casein extender or replacer |
FR2909286B1 (fr) * | 2006-12-01 | 2012-06-08 | Sanofi Pasteur | Methode d'immunisation contre les 4 serotypes de la dengue |
EP2143440A1 (fr) * | 2008-07-09 | 2010-01-13 | Sanofi Pasteur | Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués |
CA3177574A1 (en) * | 2013-03-15 | 2014-09-25 | Takeda Vaccines, Inc. | Compositions and methods for dengue virus chimeric constructs in vaccines |
US10023626B2 (en) * | 2013-09-30 | 2018-07-17 | Modernatx, Inc. | Polynucleotides encoding immune modulating polypeptides |
US10004795B2 (en) | 2015-09-08 | 2018-06-26 | Fundacao Butantan | Process for preparing an attenuated tetravalent dengue vaccine |
-
2015
- 2015-09-08 US US14/847,422 patent/US10004795B2/en active Active
- 2015-12-03 BR BR102015030332-7A patent/BR102015030332B1/pt active IP Right Grant
-
2016
- 2016-09-06 PE PE2018000360A patent/PE20181135A1/es unknown
- 2016-09-06 WO PCT/BR2016/050224 patent/WO2017041156A1/en active Application Filing
- 2016-09-06 EP EP16782176.8A patent/EP3347043A1/en active Pending
- 2016-09-06 CU CU2018000025A patent/CU24579B1/es unknown
- 2016-09-06 CR CR20180202A patent/CR20180202A/es unknown
- 2016-09-06 MX MX2018002901A patent/MX2018002901A/es unknown
- 2016-09-06 JP JP2018530944A patent/JP6968070B2/ja active Active
- 2016-09-06 AU AU2016318349A patent/AU2016318349B2/en active Active
- 2016-09-06 CN CN201680064942.3A patent/CN108289945B/zh active Active
- 2016-09-08 TW TW105129098A patent/TWI733694B/zh active
- 2016-09-08 AR ARP160102744A patent/AR105966A1/es unknown
-
2018
- 2018-03-07 MX MX2021013109A patent/MX2021013109A/es unknown
- 2018-03-08 CL CL2018000609A patent/CL2018000609A1/es unknown
- 2018-03-27 CO CONC2018/0003451A patent/CO2018003451A2/es unknown
- 2018-04-06 EC ECIEPI201826090A patent/ECSP18026090A/es unknown
- 2018-05-22 US US15/985,774 patent/US10201600B2/en active Active
-
2019
- 2019-01-22 HK HK19100940.0A patent/HK1258584A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
BR102015030332A2 (pt) | 2016-07-05 |
CN108289945B (zh) | 2022-05-31 |
WO2017041156A1 (en) | 2017-03-16 |
CO2018003451A2 (es) | 2018-11-30 |
CL2018000609A1 (es) | 2018-08-17 |
TW201718008A (zh) | 2017-06-01 |
CU20180025A7 (es) | 2018-11-06 |
MX2021013109A (es) | 2021-11-17 |
AU2016318349A1 (en) | 2018-04-19 |
JP2018527408A (ja) | 2018-09-20 |
US10201600B2 (en) | 2019-02-12 |
ECSP18026090A (es) | 2018-10-31 |
JP6968070B2 (ja) | 2021-11-17 |
AU2016318349B2 (en) | 2019-10-17 |
TWI733694B (zh) | 2021-07-21 |
BR102015030332B1 (pt) | 2019-11-05 |
CR20180202A (es) | 2018-08-10 |
MX2018002901A (es) | 2018-09-18 |
US20170065701A1 (en) | 2017-03-09 |
AR105966A1 (es) | 2017-11-29 |
US20180256702A1 (en) | 2018-09-13 |
CU24579B1 (es) | 2022-02-04 |
CN108289945A (zh) | 2018-07-17 |
US10004795B2 (en) | 2018-06-26 |
PE20181135A1 (es) | 2018-07-17 |
EP3347043A1 (en) | 2018-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201708142B (en) | Process for preparing 4-amino-pyridazines | |
HUE051531T2 (hu) | Módszer a semaglutid elõállítására | |
ZA201701415B (en) | Process for preparing pyrazoles | |
HUE059158T2 (hu) | Eljárás pridopidin elõállítására | |
HK1258584A1 (zh) | 用於製備減毒四價登革熱疫苗的方法 | |
PL3371150T3 (pl) | Sposób wytwarzania briwaracetamu | |
PL3196196T3 (pl) | Sposób wytwarzania kalcobutrolu | |
SG11201703366RA (en) | Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development | |
HK1247097A1 (zh) | 用於製備氟酮內酯的方法 | |
IL253877A0 (en) | Process for preparing 3-chloro-2-vinylphenylsulfonates | |
GB201411468D0 (en) | Novel treatment for endometriosis | |
GB201401310D0 (en) | Process for preparing membranes | |
HUE054626T2 (hu) | Eljárás D-arginil-2,6-dimetil-L-tirozil-L-lizil-L-fenilalaninamid elõállítására | |
IL246870B (en) | Method for preparing 1-alkyl-3-difluoromethyl-5-fluoro-1h-pyrazole-4-carbaldehydes and 1-alkyl-3-difluoromethyl-5-fluoro-1h-pyrazole-4-carboxylates | |
GB201608083D0 (en) | Process for preparing boscalid | |
GB2536979B (en) | Process for preparing boscalid | |
GB201508099D0 (en) | Dengue vaccines | |
GB201412839D0 (en) | Wood acetylation process | |
IL249283A0 (en) | Process for the preparation of 3-chloro-2-vinylphenol | |
GB2539022B (en) | Process for preparing boscalid | |
GB2552699B (en) | Process for preparing boscalid | |
GB2540421C (en) | Process for preparing 245cb from 243db | |
GB2552696B (en) | Process for preparing boscalid | |
SG11201709830YA (en) | Process for preparing carbazoles | |
GB201419564D0 (en) | Brewing process |